Cassey D. Bauer

Array ( [id] => 10813730 [patent_doc_number] => 20160159890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'METHODS OF TREATMENT FOR ALZHEIMER\'S DISEASE AND HUNTINGTON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/988387 [patent_app_country] => US [patent_app_date] => 2016-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 39325 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822048 [patent_doc_number] => 20160168212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'COMPOSITIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/981988 [patent_app_country] => US [patent_app_date] => 2015-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16048 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14981988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12107483 [patent_doc_number] => 09863961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-09 [patent_title] => 'Method for determination of amyloid peptides with anti-amyloid antibody' [patent_app_type] => utility [patent_app_number] => 14/977769 [patent_app_country] => US [patent_app_date] => 2015-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 24297 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14977769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13705381 [patent_doc_number] => 20170363645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => Novel Method for the Detection of pGlu-Abeta Peptides [patent_app_type] => utility [patent_app_number] => 15/536014 [patent_app_country] => US [patent_app_date] => 2015-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25846 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10980028 [patent_doc_number] => 20160176972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'Prion Protein as a Receptor for Amyloid-Beta Oligomers' [patent_app_type] => utility [patent_app_number] => 14/974442 [patent_app_country] => US [patent_app_date] => 2015-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 47171 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14974442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13645733 [patent_doc_number] => 09849165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => Oligomer-specific amyloid beta epitope and antibodies [patent_app_type] => utility [patent_app_number] => 14/971529 [patent_app_country] => US [patent_app_date] => 2015-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 15956 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14971529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10750732 [patent_doc_number] => 20160096884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 14/966175 [patent_app_country] => US [patent_app_date] => 2015-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29519 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10735931 [patent_doc_number] => 20160082081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING TRINUCLEOTIDE REPEAT DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/959470 [patent_app_country] => US [patent_app_date] => 2015-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19079 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14959470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16197415 [patent_doc_number] => 10722551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal [patent_app_type] => utility [patent_app_number] => 15/532820 [patent_app_country] => US [patent_app_date] => 2015-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19907 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12022153 [patent_doc_number] => 20170312253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'METHODS OF PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA) WITH AN EDARAVONE MEDICAMENT' [patent_app_type] => utility [patent_app_number] => 15/523855 [patent_app_country] => US [patent_app_date] => 2015-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6505 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10678052 [patent_doc_number] => 20160024197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'ANTIBODIES AGAINST AMYLOID-BETA PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/881428 [patent_app_country] => US [patent_app_date] => 2015-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22194 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14881428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11957368 [patent_doc_number] => 20170261521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'METHOD FOR DETECTING AGGREGATE FORM OF AGGREGATE-FORMING POLYPEPTIDE' [patent_app_type] => utility [patent_app_number] => 15/532185 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7815 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16430696 [patent_doc_number] => 10830775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-10 [patent_title] => Tau kinetic measurements [patent_app_type] => utility [patent_app_number] => 15/515909 [patent_app_country] => US [patent_app_date] => 2015-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 29 [patent_no_of_words] => 15325 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13168513 [patent_doc_number] => 10100362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Schizophrenia-associated genetic loci identified in genome wide association studies and methods of use thereof [patent_app_type] => utility [patent_app_number] => 14/853987 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 57 [patent_no_of_words] => 20824 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11969849 [patent_doc_number] => 20170274003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'BLOCKING PIRB UPREGULATES SPINES AND FUNCTIONAL SYNAPSES TO UNLOCK VISUAL CORTICAL PLASTICITY AND FACILITATE RECOVERY FROM AMBLYOPIA' [patent_app_type] => utility [patent_app_number] => 15/511140 [patent_app_country] => US [patent_app_date] => 2015-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24989 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11002444 [patent_doc_number] => 20160199393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'METHODS OF TREATING BRAIN ISCHEMIA OR HYPOXIA' [patent_app_type] => utility [patent_app_number] => 14/829604 [patent_app_country] => US [patent_app_date] => 2015-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 13004 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14829604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11866201 [patent_doc_number] => 20170233485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'ANTI-CD40 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/504444 [patent_app_country] => US [patent_app_date] => 2015-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 48579 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12191715 [patent_doc_number] => 09895429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'Antibodies that bind amyloid oligomers' [patent_app_type] => utility [patent_app_number] => 14/810760 [patent_app_country] => US [patent_app_date] => 2015-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11337 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14810760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13239245 [patent_doc_number] => 10132818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-20 [patent_title] => Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy [patent_app_type] => utility [patent_app_number] => 15/324141 [patent_app_country] => US [patent_app_date] => 2015-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 27539 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10654748 [patent_doc_number] => 20160000891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/792500 [patent_app_country] => US [patent_app_date] => 2015-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 46755 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 66 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14792500 [rel_patent_id] =>[rel_patent_doc_number] =>)